Aberdeen Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$12.5M Sell
2025
Q2
$14.9M Sell
2025
Q1
$18.6M Buy
2024
Q4
$10.1M Buy